Here’s one that was sent in by a reader a little while ago — it’s for Mark Skousen’s Forecasts & Strategies, which we’ve seen before a few times (the last pick we sleuthed out, China Medical, did pretty well for him).
And this is another medical technology stock, so perhaps it warrants some attention.
The stock Skousen [...]
Recent Comments